BBOT – bridgebio oncology therapeutics, inc. (US:NASDAQ)
Stock Stats
News
BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman
BBOT Presents Preclinical Data Showing RAS:PI3Ka Breaker BBO-10203 Inhibits PI3Ka/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026
BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Form 4 BridgeBio Oncology Thera For: Mar 24 Filed by: Lebowitz Peter F
Form 3 BridgeBio Oncology Thera For: Mar 24 Filed by: Lebowitz Peter F
Form 4 BridgeBio Oncology Thera For: Mar 10 Filed by: Beltran Pedro
Form 4 BridgeBio Oncology Thera For: Mar 10 Filed by: Mehra Uneek
Form 4 BridgeBio Oncology Thera For: Mar 10 Filed by: Ben Yong
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.